Advertisement
Australia markets close in 3 hours 8 minutes
  • ALL ORDS

    7,904.70
    +43.70 (+0.56%)
     
  • ASX 200

    7,648.80
    +43.20 (+0.57%)
     
  • AUD/USD

    0.6454
    +0.0017 (+0.26%)
     
  • OIL

    82.92
    +0.23 (+0.28%)
     
  • GOLD

    2,388.60
    +0.20 (+0.01%)
     
  • Bitcoin AUD

    95,739.81
    -3,216.70 (-3.25%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • AUD/EUR

    0.6042
    +0.0016 (+0.26%)
     
  • AUD/NZD

    1.0889
    +0.0016 (+0.15%)
     
  • NZX 50

    11,786.90
    -88.45 (-0.74%)
     
  • NASDAQ

    17,493.62
    -220.04 (-1.24%)
     
  • FTSE

    7,847.99
    +27.63 (+0.35%)
     
  • Dow Jones

    37,753.31
    -45.66 (-0.12%)
     
  • DAX

    17,770.02
    +3.79 (+0.02%)
     
  • Hang Seng

    16,503.97
    +252.13 (+1.55%)
     
  • NIKKEI 225

    38,090.87
    +129.07 (+0.34%)
     

Those who invested in GenusPlus Group (ASX:GNP) a year ago are up 40%

These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But you can significantly boost your returns by picking above-average stocks. To wit, the GenusPlus Group Limited (ASX:GNP) share price is 38% higher than it was a year ago, much better than the market decline of around 11% (not including dividends) in the same period. So that should have shareholders smiling. Note that businesses generally develop over the long term, so the returns over the last year might not reflect a long term trend.

Let's take a look at the underlying fundamentals over the longer term, and see if they've been consistent with shareholders returns.

View our latest analysis for GenusPlus Group

In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

ADVERTISEMENT

GenusPlus Group was able to grow EPS by 78% in the last twelve months. It's fair to say that the share price gain of 38% did not keep pace with the EPS growth. Therefore, it seems the market isn't as excited about GenusPlus Group as it was before. This could be an opportunity.

You can see how EPS has changed over time in the image below (click on the chart to see the exact values).

earnings-per-share-growth
earnings-per-share-growth

It's probably worth noting we've seen significant insider buying in the last quarter, which we consider a positive. On the other hand, we think the revenue and earnings trends are much more meaningful measures of the business. This free interactive report on GenusPlus Group's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.

What About Dividends?

It is important to consider the total shareholder return, as well as the share price return, for any given stock. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. In the case of GenusPlus Group, it has a TSR of 40% for the last 1 year. That exceeds its share price return that we previously mentioned. This is largely a result of its dividend payments!

A Different Perspective

GenusPlus Group shareholders should be happy with the total gain of 40% over the last twelve months, including dividends. We regret to report that the share price is down 3.9% over ninety days. It may simply be that the share price got ahead of itself, although there may have been fundamental developments that are weighing on it. It's always interesting to track share price performance over the longer term. But to understand GenusPlus Group better, we need to consider many other factors. Even so, be aware that GenusPlus Group is showing 2 warning signs in our investment analysis , and 1 of those shouldn't be ignored...

GenusPlus Group is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on AU exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.